Additionally, Bacteroides fragilis can promote the maturation of DCs and augment the IL-12-dependent Th1 cell immune response, thereby amplifying the anti-tumor efficacy of anti-CTLA-4 treatment (48). Here, CTLA4 is linked to neoplasm.